The synergistic effect of dexamethasone and all-trans-retinoic acid on hepatic phosphoenolpyruvate carboxykinase gene expression involves the coactivator p300

J Biol Chem. 2004 Aug 13;279(33):34191-200. doi: 10.1074/jbc.M403455200. Epub 2004 May 27.

Abstract

Activation of phosphoenolpyruvate carboxykinase (PEPCK) gene transcription in response to all-trans-retinoic acid (RA) or a glucocorticoid such as dexamethasone (Dex) requires a distinct arrangement of DNA-response elements and their cognate transcription activators on the gene promoter. Two of the accessory factor-binding elements involved in the Dex response (gAF1 and gAF3) coincide with the DNA-response elements involved in the RA response. We demonstrate here that the combination of Dex/RA has a synergistic effect on endogenous PEPCK gene expression in rat hepatocytes and H4IIE hepatoma cells. Reporter gene studies show that the gAF3 element and one of the two glucocorticoid receptor-binding elements (GR1) are most important for this effect. Chromatin immunoprecipitation assays revealed that when H4IIE cells were treated with Dex/RA, ligand-activated retinoic acid receptors (retinoic acid receptor/retinoid X receptor) and glucocorticoid receptors are recruited to this gene promoter, as are the transcription coregulators p300, CREB-binding protein, p/CIP, and SRC-1. Notably, the recruitment of p300 and RNA polymerase II to the PEPCK promoter is increased by the combined Dex/RA treatment compared with Dex or RA treatment alone. The functional importance of p300 in the Dex/RA response is illustrated by the observation that selective reduction of this coactivator, but not that of CREB-binding protein, abolishes the synergistic effect in H4IIE cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Blotting, Western
  • Carcinoma, Hepatocellular / metabolism
  • Cell Line
  • Cell Line, Tumor
  • Chromatin / metabolism
  • Dexamethasone / administration & dosage*
  • Drug Synergism*
  • E1A-Associated p300 Protein
  • Gene Expression Regulation, Enzymologic*
  • Genes, Reporter
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / metabolism
  • Hepatocytes / metabolism
  • Humans
  • Ligands
  • Liver / enzymology*
  • Liver Neoplasms / metabolism
  • Luciferases / metabolism
  • Mutation
  • Nuclear Proteins / metabolism*
  • Phosphoenolpyruvate Carboxykinase (ATP) / biosynthesis*
  • Plasmids / metabolism
  • Precipitin Tests
  • Promoter Regions, Genetic
  • Protein Structure, Tertiary
  • RNA Polymerase II / metabolism
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Trans-Activators / metabolism*
  • Transfection
  • Tretinoin / administration & dosage*
  • Tretinoin / metabolism

Substances

  • Antineoplastic Agents, Hormonal
  • Chromatin
  • Glucocorticoids
  • Ligands
  • Nuclear Proteins
  • Trans-Activators
  • Tretinoin
  • Dexamethasone
  • Luciferases
  • E1A-Associated p300 Protein
  • Ep300 protein, rat
  • RNA Polymerase II
  • Phosphoenolpyruvate Carboxykinase (ATP)